Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of July 13, 2026, MTNB trades at $0.40 with a market cap of $4.84M and a P/E ratio of -0.38. MTNB moved -47.70% today. Year to date, MTNB is +29.11%; over the trailing twelve months it is -26.67%. Its 52-week range spans $0.47 to $3.09. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MTNB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.40 |
| Market Cap | $4.84M |
| P/E Ratio | -0.38 |
| EPS | $-2.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.09 |
| 52-Week Low | $0.47 |
| Volume | 4.36M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.35M |
| Gross Margin | 0.00% |
MTNB analyst coverage data. Average price target: $0.00.